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Abstract 
Background: Pseudomonas aeruginosa is one the most important nosocomial pathogens, especially in 
immunocompromised patients. Identifying the source of contamination in health centers plays an important role 
in the control of hospital infections. The aim of this study was to determine antibiotic susceptibility and genetic 
patterns of P. aeruginosa isolated from patients hospitalized in intensive care unit of Masih Daneshvari Hospital, 
Tehran, Iran. 
Materials and Methods: Antibiotic susceptibility of the isolates was examined through 10 antibiotics 
recommended by Clinical and Laboratory Standards Institute (CLSI, 2018) guidelines using the Kirby-Bauer disc 
diffusion method. Random amplified polymorphic DNA (RAPD) analysis with the short primer of 272 was used 
to evaluate genetic relationship among the isolates and the results were analyzed by Gelcompar II software. 
Results: Of the antibiotics used, the most sensitive was found in colistin (96.4%) and the highest resistance 
rates were observed in cefotaxime (94.6%), chloramphenicol (83.9%) and imipenem (71.4%). DNA 
fingerprinting was able to identify 12 genetic patterns by RAPD-PCR technique. 
Conclusion: Antibiotic resistance in isolates of P. aeruginosa is rising and there is possibility of occurring 
outbreaks in the medical centers. Different sources of strains show their constant exchange via intra- and extra-
hospital transmission routes. Thus, according to the data of this study, there is a serious need to control sources 
of infections by physicians and staff when they are working in several sectors to control and prevent the 
transmission of the bacterium. 
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Introduction Pseudomonas aeruginosa is a major opportunistic 
Gram-negative pathogen, which is the most often 
Antibiotic resistance and RAPD-PCR genotyping of Pseudomonas aeruginosa clinical strains …                        Ghazi et al. 
NBM 53 Novelty in Biomedicine 2021, 2, 52-7 
isolated in intensive care units (ICUs)1. According to 
point-prevalence surveys carried out in the USA, 
Europe and Asia, P. aeruginosa has emerged as a 
leading cause of infections, accounting for 11-14% of 
all nosocomial infections2, which is one of the primary 
pathogens to cause infections in 
immunocompromised individuals and other highly 
vulnerable patients3. The spectrum of P. aeruginosa 
infections is broad, including respiratory, 
gastrointestinal, urinary tract infections, wound 
infections and burns. All these infections may lead to 
bacteremia, sepsis and even death4. Due to its broad 
band of natural and acquired antibiotic resistance, 
only some therapeutics reliably treats multi-drug 
resistant (MDR) P. aeruginosa infections5. Therefore, 
P. aeruginosa related infections are usually associated 
with high morbidity and mortality6. 
It is essential to understand pathogen distribution and 
its genetic relatedness to determine the epidemiology 
of hospital-acquired infections (HAIs)7,8. There have 
been various technical approaches to bacterial source 
tracking, but a consensual single method for field 
application has not been recognized until now9. The 
adaptability of P. aeruginosa to stress and phenotype 
changes are the main reason for the difficulties in P. 
aeruginosa virulence identification. It has become 
necessary to use a genotype-based system capable of 
accurate strain characterization10. Genomic 
fingerprinting techniques are currently viewed as the 
most exact strategies for the typing of 
microorganisms. These methods comprise ribotyping, 
pulsed field gel electrophoresis, and PCR-based 
fingerprinting methods. Screening by random 
amplified polymorphic DNA (RAPD–PCR) is a 
simple approach enabling the determination of clonal 
relatedness at a high speed and relatively low-cost. On 
the other hand, emergence and spread of MDR P. 
aeruginosa appear as a great public health concern in 
many parts of the world, Iran as well11. Therefore, the 
aim of our study was to evaluate antibiotic resistance 
and genotyping of P. aeruginosa in patients 
hospitalized in ICUs of Masih Daneshvari Hospital by 
RAPD–PCR. 
Methods 
Pseudomonas aeruginosa isolates 
This study has been submitted and approved by the 
ethics committee in the School of Medicine, Shahid 
Beheshti University of Medical Sciences, Tehran, Iran 
(IR.SBMU.RETECH.REC.1395.840). A total of 56 
non-duplicate clinical isolates of P. aeruginosa were 
obtained from patients hospitalized in ICUs of Masih 
Daneshvari Hospital, Tehran, Iran from March 2015 to 
May 2019. The P. aeruginosa strains isolated from 
clinical specimens of sputum, bronchial lavage and 
blood of hospitalized patients were used in the study. 
The specimens immediately transported to the 
microbiology laboratory of the Department of 
Microbiology of Shahid Beheshti University of 
Medical Sciences, Tehran, Iran. Blood culture was also 
carried out in patients with a suspicion of sepsis. 
Identification of P. aeruginosa was carried out using 
conventional methods. The tests used were a Kligler 
iron agar slant, growth in 42°C, catalase and oxidase 
tests, sugar fermentation, Simmons’ citrate agar slant, 
urea hydrolysis slant, methyl red/Voges–Proskauer test, 
and motility test. Isolates identified as P. aeruginosa 
were preserved at –70°C in trypticase soy broth 
(Merck) supplemented with 20% glycerol until further 
analysis12. 
Antibiotic susceptibility testing 
The antimicrobial susceptibility profile of the isolated 
P. aeruginosa was determined by using antibiotic 
containing disks on Mueller-Hinton agar according to 
Clinical and Laboratory Standards Institute (CLSI, 
2018) guidelines13. The disks contained the following 
antibiotics were purchased from MAST Diagnostics 
(Merseyside, UK): cefepime (30 μg), cefotaxime (30 
μg), ceftazidime (30 μg), aztreonam (30 μg), imipenem 
(10 μg), meropenem (10 μg), amikacin (30 μg), 
gentamicin (10 μg), piperacillin (100 μg), 
piperacillin/tazobactam (100/10 μg), doripenem (10 
μg), ciprofloxacin (5 μg), ticarcillin (75 μg), colistin (10 
μg). 
Random amplified polymorphic DNA typing 
(RAPD-PCR) 
In order to accomplish the genotyping of P. aeruginosa, 
bacterial genomic DNA was extracted from 200 μl of 
suspension cultured cells prepared from a single 
purified colony using QIAamp DNA Mini Kit (Qiagen, 
Hilden, Germany) according to manufacturer’s 
instruction. RAPD-PCR was done as previously 
described7. Briefly, DNA amplification was 
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accomplished on a thermocycler (Eppendorf, 
Hamburg, Germany) in a final volume of 25 μl 
containing 1× PCR buffer, 2 mM MgCl2, 1 mM dNTP 
mix, 50 mM primer 272 (3‘-AGCGGGCCAA-5‘), 1-
unit Taq polymerase (Qiagen NV, Venlo, the 
Netherlands), double distilled water, and genomic 
DNA equivalent to 40 ng. The amplification 
conditions were as follows: initial four cycles of 
denaturation at 94°C for 5 minutes, annealing at 36°C 
for 5 minutes, extension at 72°C for 5 minutes 
followed, by 30 more cycles of denaturation at 94°C 
for 1 minute, annealing at 36°C for 1 minute, and 
extension at 72°C for 2 minutes. The RAPD-PCR 
products were then electrophoresed in 1.5% (w/vol) 
agarose gel along with a 100-bp plus DNA ladder 
(SinaClon, Iran) as molecular size standard and 
banding patterns were visualized and photographed in 
gel documentation system (Uvitec, Cambridge, UK). 
Statistical analysis 
The Statistical Package for the Social Sciences (SPSS) 
software version 22 (SPSS Inc., Chicago, IL, USA) 
was used for data analysis. RAPD-PCR fingerprinting 
profile was analyzed with Gelcompar II software, 
version 6.5 (Applied Maths, Sint-Martens-Latem, 
Belgium). Comparison of the data among various group 
was performed by Chi-square test. P values <0.05 were 
considered as statistically significant. 
This study was financially supported by the Infectious 
Diseases and Tropical Medicine Research Center, 
Shahid Beheshti University of Medical Sciences, 
Tehran, Iran. 
Results 
A total of 56 P. aeruginosa isolates were obtained from 
sputum (43, 76.8%), bronchial lavage (11, 19.6%), and 
blood (2, 3.6%). Of the patients, 34 (60.7%) were males 
and 22 (39.3%) were females. The median age of the 
patients was 42 years (IQR: 9-86 years). 
Antibiotic resistance 
Percentage of antibiotic resistance in 56 evaluated P. 
aeruginosa has been shown in Table 1. Of 10 
 
Figure 1. Genotyping of Pseudomonas aeruginosa strains isolated from the intensive care unit of Masih Daneshvari Hospital. 
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antibiotics used, the highest sensitivity was observed 
to colistin (54, 96.4%) and amikacin (34, 60.7%), and 
the high frequency of antibiotic resistance was 
associated with cefotaxime (53, 94.6%) and 
chloramphenicol (47, 83.9%). 
Genotyping 
Genomic DNA was extracted from all P. aeruginosa 
isolates, and the genetic patterns of isolates were 
determined using RAPD-PCR technique using primer 
272. Based on the results obtained by RAPD-PCR, 12 
patterns were observed among the tested isolates by 
using a cut off value of 85% as the threshold. Also, no 
significant relationship was observed by examining 
the antibiogram in different patterns (P>0.05). RAPD-
PCR generated dendrogram of P. aeruginosa isolates 
is illustrated in Fig. 1. 
Discussion 
Drug resistant P. aeruginosa has emerged as one of 
the most frequently observed pathogens causing 
nosocomial infections, especially in 
immunocompromised patients14. We tested 56 P. 
aeruginosa strains isolated from different sources 
collected from patients hospitalized in the ICU, which 
caused patients to be more susceptible to many 
infections including urinary, respiratory, and 
gastrointestinal infections and sepsis15. In addition, we 
characterized and typed P. aeruginosa strains isolated 
from different clinical sources from an Iranian 
hospital according to their antibiogram and genetic 
fingerprint. 
The current examination demonstrated that the P. 
aeruginosa clinical isolates expressed a high level of 
resistance to current drugs along with obtaining 
resistance to newer antibiotics. In the present 
investigation, a high rate of antibiotic resistance was 
observed compared to other studies16,17. These results 
might be justified by the extensive usage of antibiotics 
in Iranian hospitals. Of 10 antibiotics tested from 
different classes, the highest sensitivity was observed to 
colistin (96.4%) and amikacin (60.7%); the least 
sensitivity was associated with gentamicin (50%), 
ciprofloxacin (44.6%), piperacillin (35.7%), imipenem 
(38.6%), chloramphenicol (16.1%) and cefotaxime 
(5.4%). In accordance with our findings, other studies 
from Iran have likewise indicated that besides colistin 
which acts as the choice antibiotic for treatment of 
infections caused by resistant isolates, amikacin is an 
extremely effective antibiotic as well18. Goli et al. 
uncovered that piperacillin/tazobactam (34% resistant) 
and colistin (2% resistant) had the most noteworthy 
measure of activity against MDR strains of P. 
aeruginosa 19. In a survey that conducted in Latin 
America during 2004-2015, among 3613 P. aeruginosa 
isolates, the highest susceptibility (72.8%) was seen to 
amikacin, and 56.8% of the isolates were susceptible to 
ceftazidime20. However, high rates of resistance among 
the P. aeruginosa isolates from burn patients were 
detected by Talebi et al. in Iran, which the resistance 
rates to amikacin, cefepime, ciprofloxacin, imipenem, 
ceftazidime and gentamycin were 83.8%, 85.5%, 
88.7%, 93.5%, 95.1% and 95.1%, respectively21. 
Typing of bacteria is vital for monitoring newly 
emerging pathogens and for examining local 
outbreaks22,23. In this report, we used RAPD-PCR 
followed by agarose gel electrophoresis technique for 
the molecular typing of P. aeruginosa collected from 
the patients hospitalized in the ICU of Masih 
Daneshvari Hospital. The standardization of the 
reaction conditions has contributed to making RAPD 
Table 1: The antibiotic susceptibility patterns of Pseudomonas aeruginosa isolates from patients hospitalized in 







Cefepime 27 (48.2%) 25 (44.6%) 4 (7.1%) 
Piperacillin 36 (64.3%) 20 (35.7%) 0 (0%) 
Colistin 2 (3.6%) 54 (96.4%) 0 (0%) 
Amikacin 21 (37.5%) 34 (60.7%) 1 (1.8%) 
Imipenem 40 (71.4%) 16 (28.6%) 0 (0%) 
Cefotaxime 53 (94.6%)  3 (5.4%) 0 (0%) 
Gentamicin 25 (50%) 25 (50%) 0 (0%) 
Chloramphenicol 47 (83.9%)  9 (16.1%) 0 (0%) 
Ciprofloxacin 30 (53.6%) 25 (44.6%) 1 (1.8%) 
Ceftazidime 22 (39.3%) 25 (44.6%) 9 (16.1%) 
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typing a trustworthy and reproducible technique7, with 
even more discriminatory power than DNA macro-
restriction analysis by PFGE for bacterial typing24. 
However, random amplification could simply be 
applied for the surveillance and prevention of 
nosocomial infections by clinical microbiology 
laboratories by enhancing the resolution of the 
electrophoretic separation and the sensitivity of the 
staining24. The dendrogram of genotyping of P. 
aeruginosa strains showed the presence of 12 patterns 
among the tested isolates using a cut off value of 85% 
as the threshold. There are few reports about clonal 
relationship among hospital isolates of P. aeruginosa 
in Iran. RAPD analysis by Sharifi et al. showed four 
large clusters consisting of 77 isolates out of 8424. 
Their dendrogram analysis revealed that cluster 3 
exhibited the largest fingerprint similarity consisting 
of 29 isolates. They suggested the possible spread of 
cluster 3 clones in different wards of hospitals in 
Shiraz. Taheri et al. studied the genetic similarity 
among 73 P. aeruginosa isolates from Tehran referral 
hospitals by RAPD analysis and showed 67 different 
patterns, each containing 2-3 isolates, mostly from 
ICU25. They concluded that most of the isolates were 
probably originated from the host. 
The number of genotypes, as in our case, presumably 
reflects the various sources of strains and their 
constant exchange via intra- and extra-hospital routes 
through transient hand carriage by health care 
personnel due to contact with contaminated surfaces26. 
These assumptions were supported by the dates of 
strain isolation, when individual genotypes were 
found independently on the term and length of 
patient’s hospitalization. Even rare genotypes were 
recovered either on the first day of hospitalization or 
after more than 30 days of hospitalization. Taken 
together, both higher stability and discriminatory 
power make genotype determination by RAPD 
analysis a more accurate tool to analyze the 
epidemiological situation in the hospital than 
serotyping. We searched for the fast, simple and low-
cost approach for profiling P. aeruginosa strains and, 
based on several other studies27,28, RAPD analyze was 
finally considered as a suitable method for this 
purpose, being beneficial even when used separately. 
RAPD can be used as a first screen in characterization 
of P. aeruginosa strains, allowing quick 
characterization of molecular differences between 
various groups of isolates4. Yet the following genotypic 
and/or phenotypic characterization should be used for 
acquisition of more exact information about particular 
strains4. 
Conclusion 
Based on the results, it can be concluded that our P. 
aeruginosa hospital isolates are highly resistant to 
different classes of antibiotics and sensitive to colistin, 
which could be used as an empirical therapy in critically 
ill patients, especially in patients admitted to ICU. 
Further studies on a larger number of isolates are 
required to confirm our observations. We suggest 
applying strict disinfection policy in a hospital to 
prevent spreading of infections, also, new classes of 
antibiotics should replace traditional antibiotic 
treatment to prevent emergence of resistant strains of P. 
aeruginosa. 
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